SIME begins clinical trial validating point-of-care device that rapidly predicts neonatal respiratory disease at birth in the NICUFeb 7, 2023
SIME AI device that predicts acute respiratory disease receives CE Mark – changing the standard of care for millions of babies worldwideNov 11, 2022
Early prediction of newborn Chronic Lung Disease is urgently needed for effective treatmentMay 25, 2022